(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TESSERA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TESSERA

ST13

US500000088642455

Class

1, 5

Filing

88642455

Registration

6494020

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

04/06/2023

Trademark type

Word

Nice classes

1, 5

Filing date

10/04/2019

Registration date

09/21/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/21/2021

Last transaction

09/21/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/27/2021

First use in commerce

05/27/2021

Drawing code

4

Owner type

03

Owner location

Somerville, MA

Examiner

MISCHLER, MEGAN

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TESSERA THERAPEUTICS, INC.
TESSERA THERAPEUTICS, INC.
Flagship VL58, Inc.

Representatives

Christina M. Licursi, Esq. WOLF GREENFIELD & SACKS, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical and biological agents for scientific and research usefor manipulating or modifying DNA; technology for enabling the engineering and modification of DNAmolecular and cellular biology reagents and assays for the modification of cells and DNA

Class 5

Pharmaceutical preparations and therapeutic agentsfor gene therapy and DNA editing; pharmaceutical and biological preparations based on genegenomecellular editingmodulationmodification for use in human therapeutics; pharmaceutical preparationstherapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders

Publications

History of USPTO decisions and trademark events.

36 publications found

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/06/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/06/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/21/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/17/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/16/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/13/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/13/2021

IUAF

USE AMENDMENT FILED

08/03/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/03/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/03/2021

EX1G

SOU EXTENSION 1 GRANTED

02/01/2021

EXT1

SOU EXTENSION 1 FILED

02/01/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/01/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/09/2020

PUBO

PUBLISHED FOR OPPOSITION

06/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

04/28/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/28/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

04/28/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/28/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/20/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/20/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/20/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/09/2020

GNRT

NON-FINAL ACTION E-MAILED

01/09/2020

CNRT

NON-FINAL ACTION WRITTEN

01/09/2020

DOCK

ASSIGNED TO EXAMINER

01/09/2020

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

11/12/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/12/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/08/2019

Continuous trademark protection

Get notified about every new filing that threatens TESSERA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.